About this trial
The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.
Eligibility criteria
Qualifiers
Age 8-70 years
Ability to perform spirometry and oscillometry
Signed informed consent (and assent for children as appropriate)
No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases
Disqualifiers
Inability or unwillingness to perform AWARE, spirometry, or oscillometry
Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS)
Trial design
Treatments tested in this trial
- AWARE
Treatment groups
Sponsors and collaborators
Indiana University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
University of Pittsburgh
Collaborator